Related Experiment Video
Updated: May 5, 2026

Ferric Chloride-induced Thrombosis Mouse Model on Carotid Artery and Mesentery Vessel
Published on: June 29, 2015
Ceftriaxone-Induced Thrombocytopenia: A Case Report on a Rare Medical Condition
Badri Aryal1, Audrey Simmons2, Giri Ekkurthi2
1Internal Medicine, John H. Stroger, Jr. Hospital of Cook County, Chicago, USA.
Abstract:
We present a case of antibody-confirmed drug-induced thrombocytopenia (DITP) caused by ceftriaxone. DITP is a rare but potentially life-threatening cause of isolated thrombocytopenia in the inpatient setting, often leading to critically low platelet levels. The underlying mechanism is believed to be an immune-mediated response, where drug-dependent antibodies bind to glycoproteins on the platelet membrane in the presence of the offending drug, resulting in platelet destruction and thrombocytopenia. We describe a case of ceftriaxone-induced thrombocytopenia in a patient being treated for aspiration pneumonia complicated by sepsis. To the best of our knowledge, only eight similar cases have been reported in the literature.
Related Concept Videos
Drugs for Treatment of Crohn's Disease in IBD Using Biologic Agents: Anti-TNF
Drug toxicity: Idiosyncratic Reactions
Diphtheria
Inhibitors of Bacterial DNA Synthesis
Transient Ischemic Attack l: Introduction

